Theranostic nanoparticles.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Theranostic nanoparticles combine diagnostic and therapeutic capabilities for disease management.
• Significant research has focused on engineering these nanoparticles for simultaneous cancer imaging and therapy.
• Effective tumor targeting is crucial for the efficacy of theranostic nanoparticles in diagnosis and treatment.

Purpose of the Study:

• To review the current and prospective status of actively tumor-targeting theranostic nanoparticles.
• To highlight the engineering challenges associated with developing specific in vivo tumor-targeting capabilities.
• To discuss the potential of theranostic nanoparticles in revolutionizing cancer management.

Main Methods:

• Literature review of recent advancements in theranostic nanoparticle engineering.
• Analysis of studies focusing on in vivo tumor targeting strategies.
• Discussion of biocompatibility and specificity challenges in nanoparticle design.

Main Results:

• Growing interest in engineering theranostic nanoparticles for dual imaging and therapy applications.
• Demonstrated progress in developing nanoparticles with some tumor-targeting capabilities.
• Persistent difficulties in achieving highly specific and biocompatible in vivo tumor targeting.

Conclusions:

• Theranostic nanoparticles show great potential for cancer management.
• Further engineering efforts are needed to overcome challenges in specific in vivo tumor targeting.
• Advancements in biocompatible theranostic nanoparticle design are critical for clinical translation.